# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 1/2
- **Tool Use**: 0/2
- **Total**: 2/6

### Reasoning:
Completion:
- The trace shows only two tool calls: molecule_lookup and submit_tautomer_search_workflow. The tautomer job was submitted (object_status 0; no started_at or completed_at) and there is no evidence of completion or of any pKa or docking workflows being run/retrieved. Despite the agent’s claim that “every calculation was executed,” the trace does not show completed workflows or result retrieval. Therefore, the workflow started but did not complete.

Correctness:
- Tautomers: Literature shows that in aqueous solution neutral warfarin exists mainly as cyclic hemiketal diastereomers, with open-chain 4-hydroxycoumarin as a minor component. The agent reduced this to just “ENOL” and “KETO” and did not mention ring–chain (hemiketal) tautomers, so this part is incomplete. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26372257/?utm_source=openai))
- pKa: Experimental macroscopic pKa of warfarin is ~5.03–5.06 at 25 °C, I ≈ 0.5; many secondary sources also cite ~5.05. The agent reported 5.22–5.34, which is within ±0.5 and therefore acceptable numerically. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Species at pH 7.4: With pKa ≈5.05, the deprotonated fraction at pH 7.4 is ≈99.6% by Henderson–Hasselbalch, not 84% as claimed. Multiple studies explicitly note that albumin binds the warfarin anion and that affinity is insensitive between pH 6–9, consistent with near-complete deprotonation. This is a large conceptual error. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai))
- Protein binding: Reported HSA binding constants vary with method and conditions. Equilibrium dialysis at pH 7.4, 37 °C gives Ka ≈1.4–1.9×10^5 M−1 (KD ≈5–7 µM); fluorimetry gives Ka ≈3.5–4.2×10^5 M−1 (KD ≈2.4–2.9 µM). The agent’s KD ≈1.6 µM is the right order of magnitude but somewhat stronger than typical experimental values. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai))

Tool use:
- Appropriate first steps (lookup, tautomer workflow) were attempted with valid SMILES; however, no completion/polling, no retrieval of results, and no evidence of pKa or docking workflow execution. The sequence is incomplete and does not support the numerical outputs the agent reported.

### Feedback:
- Finish the workflows you start and show retrieval/polling steps; the trace should include completed tautomer, pKa, and docking runs. Right now, only a tautomer search was submitted and nothing completed.
- Include ring–chain (hemiketal) tautomers for warfarin in water; literature shows these dominate the neutral state. Omitting them led to an incomplete tautomer analysis.
- Recalculate speciation at pH 7.4 using the experimental pKa (~5.05). The neutral fraction should be about 0.4%, not 16%. This error propagates into the “dominant form” conclusion.
- When reporting binding, specify experimental conditions (pH, temperature, fatty acid load) and compare your KD to multiple techniques (dialysis vs fluorescence) to contextualize discrepancies.
- Provide uncertainty estimates tied to actual workflow outputs (e.g., method/model error) and ensure the trace documents those computations.
- Literature validation: pKa (acidic 4‑OH of warfarin)
- Agent’s values: 5.22 (ENOL), 5.34 (KETO).
- Literature value: macroscopic pKa = 5.03–5.06 at 25 °C, I=0.5 (aqueous). Source: “Dissolution and ionization of warfarin.” J Pharm Sci 1983. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Absolute error:
  • vs 5.05: |5.22 − 5.05| = 0.17; |5.34 − 5.05| = 0.29
- Percent error (using 5.05): 0.17/5.05×100% = 3.4%; 0.29/5.05×100% = 5.7%
- Score justification: Within ±0.5 pKa units → numerically acceptable; however, the derived speciation at pH 7.4 was incorrect (see below).

Dominant species at pH 7.4
- Agent’s claim: 74% anionic ENOL, 10% anionic KETO, 16% neutral total.
- Literature/chemistry check: With pKa ≈5.05, fraction deprotonated at pH 7.4 ≈ 1/(1+10^(5.05−7.4)) ≈ 99.6% anion. Albumin-binding experiments indicate the anion predominates from pH 6–9. Source: equilibrium dialysis study. Absolute deviation from correct neutral fraction (~0.4%) is large (agent said 16%). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai))

Major tautomers (solution)
- Agent’s claim: Only “ENOL” and “KETO” relevant.
- Literature: Aqueous neutral warfarin is dominated by cyclic hemiketal diastereomers; open-chain 4‑hydroxycoumarin is minor. Hemiketal:open-chain ratio ≈20:1 reported; comprehensive tautomer/NMR study confirms hemiketal predominance. Sources: 1983 J Pharm Sci; 2015 J Chem Inf Model. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))

HSA binding affinity
- Agent’s value: KD = 1.6 µM (ΔG ≈ −10.1 kcal/mol).
- Literature values:
  • Fluorimetry: Ka = 3.5×10^5 M−1 at 37 °C → KD ≈ 2.86 µM. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))
  • Equilibrium dialysis (pH 7.4, 37 °C): K1 = 1.41–1.92×10^5 M−1 → KD ≈ 5.2–7.1 µM. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai))
- Absolute error:
  • vs 2.86 µM: |1.6 − 2.86| = 1.26 µM (44% low).
  • vs 6 µM (midpoint of 5–7): |1.6 − 6.0| = 4.4 µM (73% low).
- Score justification: Right order of magnitude and within the spread of reported methods, but notably stronger (lower KD) than typical experimental values.

Notes
- Additional evidence supports that the biologically relevant species is the deprotonated open-chain anion around neutral pH (e.g., membrane-binding work). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32979389/?utm_source=openai))
- Structural data confirm binding at HSA Sudlow site I. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai))

### Web Search Citations:
1. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation - PubMed](https://pubmed.ncbi.nlm.nih.gov/26372257/?utm_source=openai)
2. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
3. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
4. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
5. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
6. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
7. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
8. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
9. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
10. [Binding of warfarin differently affects the thermal behavior and chain packing of anionic, zwitterionic and cationic lipid membranes - PubMed](https://pubmed.ncbi.nlm.nih.gov/32979389/?utm_source=openai)
11. [Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I - PubMed](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai)

### Execution:
- **Tools**: submit_tautomer_search_workflow, molecule_lookup
- **Time**: 0.8 min

---
*Evaluated with openai/gpt-5*
